Across-cohort QC analyses of GWAS summary statistics from complex traits by Chen, Guo-Bo et al.
ARTICLE
Across-cohort QC analyses of GWAS summary statistics
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Guo-Bo Chen*,1, Sang Hong Lee1,2, Matthew R Robinson1, Maciej Trzaskowski1, Zhi-Xiang Zhu3,
Thomas W Winkler4, Felix R Day5, Damien C Croteau-Chonka6,7, Andrew R Wood8, Adam E Locke9,
Zoltán Kutalik10,11,12, Ruth J F Loos13,14,15, Timothy M Frayling8, Joel N Hirschhorn16,17,18,19, Jian Yang1,20,
Naomi R Wray1, The Genetic Investigation of Anthropometric Traits (GIANT) Consortium21
and Peter M Visscher*,1,20
Genome-wide association studies (GWASs) have been successful in discovering SNP trait associations for many quantitative traits
and common diseases. Typically, the effect sizes of SNP alleles are very small and this requires large genome-wide association
meta-analyses (GWAMAs) to maximize statistical power. A trend towards ever-larger GWAMA is likely to continue, yet dealing
with summary statistics from hundreds of cohorts increases logistical and quality control problems, including unknown sample
overlap, and these can lead to both false positive and false negative findings. In this study, we propose four metrics and
visualization tools for GWAMA, using summary statistics from cohort-level GWASs. We propose methods to examine the
concordance between demographic information, and summary statistics and methods to investigate sample overlap. (I) We use
the population genetics Fst statistic to verify the genetic origin of each cohort and their geographic location, and demonstrate
using GWAMA data from the GIANT Consortium that geographic locations of cohorts can be recovered and outlier cohorts can be
detected. (II) We conduct principal component analysis based on reported allele frequencies, and are able to recover the
ancestral information for each cohort. (III) We propose a new statistic that uses the reported allelic effect sizes and their
standard errors to identify significant sample overlap or heterogeneity between pairs of cohorts. (IV) To quantify unknown sample
overlap across all pairs of cohorts, we propose a method that uses randomly generated genetic predictors that does not require
the sharing of individual-level genotype data and does not breach individual privacy.
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INTRODUCTION
To elucidate genetic architecture, which requires maximized statistical
power for discovery of risk alleles of small effect, large genome-wide
association meta-analyses (GWAMAs) are tending towards ever-larger
scale that may contain data from hundreds of cohorts. At the
individual cohort level, genome-wide association study (GWAS)
analysis is often based on various genotyping chips and conducted
with different protocols, such as different software tools and reference
populations for imputation, inclusion of study-specific covariates and
association analyses using different methods and software. Although
solid quality control (QC) analysis pipelines of GWAMA exist,1 these
analyses focus on QC for each cohort independently. With ever-
increasing sizes of GWAMA, there is a need for additional QC that
goes beyond the cohort-by-cohort genotype-level analysis performed
to date.
In this study, we propose a new set of QC metrics for GWAMA. All
these applications assume that there is a central analysis hub, where
summary statistic data from GWAS are uploaded for each cohort. All
methods proposed are implemented in freely available software GEAR.
MATERIALS AND METHODS
Overview of materials and methods
Cohort-level summary statistics. The height GWAS summary statistics were
provided by the GIANT Consortium and were from 82 cohorts (174 separate
files) representing a total of 253 288 individuals, and ~2.5 million autosomal
SNPs imputed to the HapMap2 reference.2 Metabochip summary statistics for
body mass index (BMI) were from 43 cohorts (120 files), representing a total of
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103 047 samples from multiple ethnicities with about 200 000 SNPs genotyped
on customised chips.3,4
1000 Genomes project samples. 1000 Genomes Project (1KG) reference
samples5 were used as the reference samples for estimating Fst and meta-PC.
When assessing the global-level Fst measures, Yoruba represent African samples
(YRI, 108 individuals), Han Chinese in Beijing represent East Asian samples
(CHB, 103 individuals), and Utah Residents with Northern and Western
European Ancestry represent European samples (CEU, 99 individuals) were
employed as the reference panels. For calculating within-Europe Fst, CEU,
Finnish (FIN, 99 individuals), and Tuscani (TSI, 107 individuals) were
employed to represent northwest, northeast, and southern Europeans, respec-
tively. For analyses using a whole European panel, CEU, FIN, TSI, GBR
(British, 91 individuals), and IBS (Iberian, 107 individuals) were pooled
together as an ‘averaged’ European reference.
WTCCC GWAS data. WTCCC GWAS data has 2934 shared controls for seven
diseases with a total of 14 000 cases.6 Individual GWAS was conducted for each
disease using PLINK7 and their summary statistics used to estimate λmeta.
The four proposed metrics include:
Fpc: a genome-wide comparison of allele frequency differences across
cohorts or against a common reference population.
Meta-PC: principal component analysis of reported allele frequencies.
λmeta: a pairwise cohort statistic that uses allele frequency or effect size
concordance to detect the proportion of sample overlap or
heterogeneity.
Pseudo profile score regression: an easy to implement analysis to
pinpoint each between-cohort overlapping sample that does not
require the sharing of individual-level genotype data.
The technical details of these four methods summarized here can be found
in the Supplementary Notes. Overview and application of these four metrics in
GWAMA can be found in the Text Box.
RESULTS
Population genetic QC analysis using Fst
In GWAMA, only summary statistics such as allele frequencies are
available to the central analysis hub, it is difficult to identify
population outliers. Gross differentiation in allele frequencies at
specific SNPs between GWAMA cohorts and a reference (such as
1000 Genomes Project, denoted as 1KG)5 are part of standard QC
protocols,1 but checking for more differentiation than expected across
the entire genome is not usually part of the QC pipeline. We propose
that a genetic distance inferred from Fst, which reflects genetic distance
between pairwise populations, is a useful additional QC statistic to
detect cohorts that are population outliers. Using the relationship
between Fst and principal components,
8 our Fst cartographer algo-
rithm can be used to estimate the relative genetic distance between
cohorts (Supplementary Notes for Method I; Supplementary
Figure S1).
We applied the Fst metric to the GIANT Consortium BMI
Metabochip cohorts (55 male-only cohorts, 55 female-only cohort,
and 10 mixed-sex cohorts), which were recruited from multiple
ethnicities,3 such as Europeans, African Americans in the Athero-
sclerosis Risk in Communities Study (ARIC) and cohorts from
Jamaica (SPT), Pakistan (PROMISE), Philippines (CLHNS), and
Seychelles (SEY). For each Metabochip cohort, we sampled 30 000
independent markers to calculate Fst values with each of three 1KG
samples (CEU, CHB, and YRI, respectively). For validation of the
method, we also calculated Fst values against the 1KG Japanese (JPT,
Japanese in Tokyo, Japan), Indian (GIH, Gujarati Indian in Houston,
US), Kenyan (LWK, Luhya in Webuye, Kenya), and European samples
(IBS, Iberian populations, Spain; FIN, Finnish, Finland; TSI, Toscani,
Italy, and GBR, British in England, and Scortland, GBR), to see
whether the known genetic origins of those cohorts can be recovered.
According to the origins of the samples, each Metabochip cohort
showed a different genetic distance spectrum to the three reference
populations (Figure 1a). The JPT and Philippine cohorts had very
small genetic distances to CHB, as expected, but large to CEU and
YRI; however, the Pakistan cohorts showed much closer genetic
Box 1 Genome-wide association meta-analysis QC in a nutshell
Metric 1: Fst-based inference of cohort origins
Fst reflects genetic relatedness for cohorts, and consequently can be used to
infer or confirm the genetic origins of cohorts. For example, the PROMISE
cohort, which is from Pakistan, had its global-level coordinates between CEU
(Europeans) and CHB (east Asians), and was very close to GIH (Indians), which
agrees with the demographic history of the Pakistani population (Figure 1).
Metric 2: meta-PCA inference of cohort origins
Meta-PCA resembles conventional genotype-based PCA8, but the input data are
the reported allele frequencies of cohorts rather than individual genotypes,
hence summary statistics. Once a cohort has a projection that disagrees with its
demographic history, the central meta-analysis hub should contact the individual
cohort manager for clarification (Figure 4).
For metrics 1 and 2, the inferred cohort origins can be projected at a global or
regional level. For example, CEU, YRI, and CHB can be chosen as global
reference populations, and CEU, FIN, and TSI chosen as within-Europe
reference populations.
Diagnosis: The central meta-analysis hub is suggested to implement either
metric 1 or metric 2 once the summary statistics are received. These two metrics
can rule out major errors such as incorrectly generated summary statistics (such
as wrong reference allele frequencies) or incorrectly uploaded files.
Metric 3: λmeta for detecting unusual sampling properties for a pair of cohorts.
λmeta examines a pair of cohorts for: (1) E(λmeta)=1 if a pair of cohorts is
consistent by being samples drawn from the same population; (2) E(λmeta)o1 if
a pair of cohorts is too similar, such as due to overlapping samples; (3) E(λmeta)
41, if a pair of cohorts is too dissimilar, such as due to different data analysis
protocols or difference in genetic architecture. Summary statistics are often
generated from different protocols, which introduce technical heterogeneity and
push the empirical lmeta is often slightly 41 (Figure 2b). For statistical test for
overlapping samples between any pair of cohorts, its z-score can be constructed as
z ¼ ðl^meta1Þs^lmeta , in which s^lmeta can be estimated from all possible pairs of λmeta between
the cohorts in a GWAMA. As demonstrated, an outlier cohort often generates a special
pattern in the distribution of λmeta (see the blue bands at the off-diagonal space in
Figure 2a).
The central meta-analysis hub can use the distribution/heat map of λmeta to
monitor the abnormality of the reported genetic effects and potential overlapping
samples. In addition, λmeta for all pairs of cohorts makes a correlation matrix,
which can be integrated into generalized meta-analysis for the correction of
overlapping samples.21
Diagnosis: If a cohort is observed to have l^metao1 with many other cohorts, it may
reflect other systematic issues, such as accidentally λGC correction is implemented, but
should not, for the raw summary statistics. If a cohort has l^meta41 with many other
cohorts, it may reflect a very different protocol is used in generating the summary
statistics, or may reflect its very different genetic architecture.
Metric 4: PPSR for pinpointing overlapping samples
When λmeta provides strong evidence for a proportion of overlapping samples
between a pair of cohorts, PPSR can further pinpoint the exact overlapping
individuals/relatives included in these two cohorts. PPSR is better to solve an
unreasonable small value λmeta between a pair of cohorts, say λmetao0.8, and its
implementation should be coordinated by the central analyst, who can balance
the quality of the summary statistics and identification concerns (Figure 3d).
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distances to CEU than to CHB and YRI, indicating their demographic
history. The cohorts sampled from Jamaica, Seychelles, Hawaii, and
the African American ARIC cohort had small genetic distances to YRI,
but large distances to CHB and CEU. For most European cohorts, as
expected, the distances to CEU were very small compared with those
to CHB and YRI. Given their relative distances to CEU, CHB, and
YRI, using our Fst cartographer algorithm (Supplementary Notes for
Method I; Supplementary Figure S1), the cohorts were projected into a
Figure 1 Recovery of cohort-level genetic background and inference of their geographic locations for GIANT BMI Metabochip cohorts and GIANT GWAS
height cohorts using the Fst-derived genetic distance measure. (a) Genetic distance spectrum for all Metabochip cohorts to CEU, CHB, and YRI. The origins
of the cohorts are denoted on the horizontal axis. (b) Projection for the Metabochip cohorts into FPC space defined by YRI, CHB, and CEU reference
populations. The x and y axis represent relative distances derived from the genetic distance spectrum. Three dashed lines, blue for CEU, green for CHB, and
red for YRI, partitioned the whole FPC space to three genealogical subspaces. (c) The genetic distance spectrum for the Metabochip European cohorts to CEU
– northwest Europeans, FIN – northeast European, and TSI – southern Europeans. The nationality of the cohorts is denoted on the horizontal axis. (d) The
projection for the Metabochip European cohorts to the FPC space defined by CEU, FIN, and TSI reference populations. The whole space is further partitioned
into three subspaces, CEU-TSI genealogical subspace (red and blue dashed lines), FIN-TSI genealogical subspace (green-blue dashed lines), and CEU-FIN
genealogical subspace (red-green dashed lines), respectively. (e) Each cohort has three Fst values by comparing with CEU, FIN, and TSI reference samples.
The height of each bar represents its relative genetic distance to these three reference populations. The nationalities of the cohorts are denoted along the
horizontal axis. The grey triangles along the x axis indicate MIGEN cohorts. (f) Given the three Fst values, the location of each cohort can be mapped. The
whole space was partitioned into three subspaces, CEU-TSI genealogical subspace (red and blue dashed lines), FIN-TSI genealogical subspace (green and
blue dashed lines), and CEU-FIN genealogical subspace (red and green dashed lines). DGI (in the blue box) had samples from the Botnia study. Across the
MIGEN cohorts (denoted as red triangles in the red box), the same allele frequencies (likely calculated from a South European cohort) were presented for
each cohort. The open circles represent the mean of inferred geographic locations for the cohorts from the same country. Cohort/country codes: AF, African;
AU, Australia; CA, Canada; CH, Switzerland; DE, Germany; DK, Denmark; EE, Estonia; ES, Iberian Population in Spain in 1KG; EU, European Nations; FI,
Finland; FIN, Fins in 1000 Genomes Project (1KG); FR, France; GBR, British in 1KG; GIB, Gujarati Indian in 1KG; GR, Greece; Hawaii, Hawaii in USA;
IBS, Iberian Population in Spain in 1KG; IT, Italy; IS, Iceland; JM, Jamaica; JPT, Japanese in 1KG; LWK, Luhya in 1KG; NL, Netherlands; NO, Norway; PH,
the Philippines; PK, Pakistan; SC, Seychelles; SCT, Scotland; SE, Sweden; TSI, Tuscany in 1KG; UK, United Kingdom; US, United States of America.
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two-dimensional space, called Fst-derived principal components (FPC)
space, constructed by YRI, CHB, and CEU as the reference popula-
tions (Figure 1b). The allocation of the cohorts to the FPC space
resembles that of eigenvector 1 against eigenvector 2 in principal
component analysis (PCA), and is similar to those observed in PCA
using individual-level GWAS data for populations of various ethni-
cities such as in 1KG samples.5 Therefore, our method to place
cohorts in geographical regions from GWAS summary statistics works
well at a global-population scale.
We next investigated whether our genetic distance method works at
a much finer geographic scale. It is known that using individual-level
data, PCA can mirror the geographic locations for European samples.9
Here we analyzed the 103 GIANT European-ancestry Metabochip
cohorts (48 male-only cohorts, 47 female-only cohorts, and 8 mix-sex
cohorts) for fine-scale Fst genetic distance measure using the CEU,
FIN, and TSI reference populations, which represent northwest,
northeast, and southern European populations, respectively. For each
of the GIANT European-ancestry Metabochip cohorts, Fst was
calculated relative to each of these three reference populations and
showed concordance with the known origin of the samples
(Figure 1c). For example, cohorts from Finland and Estonia were
close to FIN but distant to TSI; cohorts from South Europe such as
Italy and Greece had small genetic distance to TSI; and cohorts from
West Europe had small genetic distance to CEU. Similarly, the
projected origin for each European-ancestry Metabochip cohort
resembles its geographic location within the European map as
expected (Figure 1d). Therefore, Fpc based upon population differ-
entiation also works at a fine scale.
We next applied the Fst genetic distance measures to 174 GIANT
height GWAS cohorts (79 male-only cohorts, 76 female-only cohorts,
and 19 mixed-sex cohorts; excluding Metabochip data), which were all
of European ancestry imputed to the HapMap reference panel.2 Given
the three Fst values to CEU, FIN, and TSI (Figure 1e), the geographic
origin for each cohort can be inferred as for the GIANT BMI
Metabochip data. The projected coordinates of each GWAS cohort
matches its origin very well (Figure 1f). For example, a Canadian
cohort, the Quebec Family Study (QFS), was closely located to DESIR,
a French cohort, consistent with the French genetic heritage of the
QFS.10 In addition, we also observe complexity due to mixed samples
from different countries. For example, the DGI/Botnia study had
Figure 2 λmeta for the GIANT height GWAS cohorts. (a) Given 174 cohorts, there are 15 051 λmeta values, which provide the overview of the quality control of
the summary statistics. The heat map represents 15 051 λmeta statistics, and the x and y axis index each pair of cohorts. The pairs of cohorts showed
heterogeneity (l^meta41) are illustrated on left-top triangle, and homogeneity (l^metao1) on right-bottom triangle. (b) The distribution of λmeta from 174
cohorts/files used in the GIANT height meta-analysis. The overall mean of 15 051 λmeta is 1.013, and SD is 0.022. (c) Illustration for homogeneity between
two cohorts (SORBS MEN and WOMEN), λmeta=0.876. (d) Illustration of SardiNIA and WGHS, this pair of cohorts has λmeta=1.245. The grey band
represents 95% confidence interval for λmeta.
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Figure 3 Pseudo profile score regression for pinpointing overlapping samples/relatives. (a) Each cluster represents a pair of cohorts as denoted on the x axis.
Within each cluster, from left to right, the detected overlapping controls using λmeta based either on effect size estimates or minor allele frequency (MAF), PPRS
using 100, 200, and 500 markers. WTCCC cohort codes: BD for bipolar disorder, CAD for coronary artery disease, CD for Crohn’s disease, HT for hypertension,
RA for rheumatoid arthritis, T1D for type 1 diabetes, and T2D for type 2 diabetes. (b) Illustration for regression coefficients between WTCCC BD and CAD from
57 pseudo profile scores (PPS) generated from 500 markers. The x axis is the PPSR regression coefficients and y axis is real genetic relatedness (as calculated
from individual-level genotype data). The red points are the shared controls between two cohorts, and blue points are first-degree relatives. (c) The PPS regression
coefficients for detecting overlapping first-degree relatives using 286 PPS generated from 500 markers. (d) Decoding genotypes from the PPS. Given the set of
profile scores, one may run a GWAS-like analysis to infer the genotypes. The ratio between the number of markers (M) and number of pseudo profile scores (K)
determines the potential discovery of individual-level information. The higher the ratio and, the higher the allele frequency, the less information can be recovered.
From left to right, the profile scores generated using different number of markers. The y axis is a R2 metric representing the accuracy between the inferred
genotypes and the real genotypes. From left to right panels, 100, 200, 500, and 1000 SNPs were used to generate 10, 20, 50, and 1000 profiles scores. In
each cluster, the three bars are inferred accuracy using different MAF spectrum alleles, given the SE of the mean.
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samples recruited from Sweden and Finland, and its inferred
geographic location is in between of the Swedish cohorts and Finnish
cohorts.11 We also note that for the Myocardial Infarction Genetics
Consortium (MIGEN) cohorts, which are recruited from Finland,
Sweden, Spain, and the United States, the same allele frequencies were
reported for all their sub-cohorts, and all cohorts were allocated to
southern Europe (very closely located to 1KG IBS cohort; Figure 1f
and Supplementary Figure S2). As the allele frequencies, used in QC
steps to eliminate low-quality loci, were not directly used in estimating
genetic effects in the GWAMA, the reported allele frequencies in
MIGEN have not impacted much on the published GWAMA results.2
Next, we show that Fst can detect populations that have a different
demographic past. Using all 1KG European samples as the reference
panel (eg, an ‘averaged’ European reference panel), most cohorts in
GIANT had Fsto0.005 with this average, which agrees with previously
reported results using individual-level data from European nations.9 A
few cohorts showed large Fst, such as the AMISH cohort with
Fst= 0.018, and the North Swedish Population Health Study12 with
Fst= 0.014. Both populations are known to have been genetically
isolated (Supplementary Figure S3).
PCA for allele frequencies (meta-PCA)
Given the same allele frequencies as used for Fst-based analysis above,
we conducted PCA for allele frequencies, denoted as meta-PCA (or
mPC). In meta-PCA, each cohort was analogously considered as an
‘individual’. For example, 120 Metabochip cohorts were considered as
a sample of 120 ‘individuals’. Although the inferred ancestral
information was for each cohort rather than any individuals,
implementation of meta-PCA was the same as the conventional
PCA (Supplementary Notes for Method II). Meta-PCA was tested
with 1KG samples. It indicated that meta-PCA could reveal the genetic
background for each cohort as precisely as that based on individual-
level data (Supplementary Figure S4).
We applied meta-PCA to 120 Metabochip cohorts for nearly 34K
common SNPs between Metabochip and 1KG variants, with the
inclusion of 10 1KG cohorts (East Asian: CHB and JPT; South Asian:
GIH; European: CEU, FIN, GBR, IBS, and TSI; African: LWK and
YRI) as the reference cohorts. Consistent with demographic informa-
tion, the inferred ancestral information of each cohort agreed well
with demographic information. For example, PROMISE (Pakistan)
located very close to GIH, CLHNS (Philippines) close to CHB and
JPT, ARIC (African American) and SPT (Jamaican) close to YRI and
LWK, and the European cohorts close to CEU and FIN (Figure 4a).
We also applied meta-PCA to 174 GIANT height GWAS cohorts for
nearly 1M SNPs, with the inclusion of 10 1KG reference cohorts. At
the global-population level, the 174 cohorts were all allocated close to
CEU and FIN, consistent with their reported demographic informa-
tion (Figure 4b). For fine-scale inference, we conducted meta-PCA
again but with the inclusion of the five 1KG European samples. As
demonstrated (Figure 4c), the resolution of the inferred relative
location between European cohorts reflected their real geographical
locations, as previously observed using individual-level data.9 For
example, of the four cohorts from Italy, the MICROS cohort was from
South Tyrol, northern Italy. MICROS had its meta-PC coordinates
much closer to CEU than another three Italian cohorts, reflecting its
geographic location; the InCHIANTI cohort had its coordinates
almost identical to TSI; the cohort SardiNIA located more southward
than TSI, reflecting its relative geographic and genetic isolation as
recently confirmed.13 Similarly, in the sub-plots for Finland and
Sweden, the cohorts from the MIGEN consortium, which all had
reported allele frequencies of south Europe origin, were located near
1KG TSI and IBS.
These results were consistent to what was observed from Fpc as
described in the last section, and also agreed well with demographic
information. Therefore, based on the reported allele frequencies, the
demographic information could be verified by the meta-PCA method.
λmeta to detect pairwise cohort heterogeneity and sample overlap
In this study, we use the summary statistics for a pair of cohorts to
calculate λmeta, a metric that examines heterogeneity from the
concordance of reported effect sizes and sampling variance. For a
SNP marker (i), given its reported estimated effect size (bi) and
sampling variance (σi
2) in a pair of cohorts 1 and 2, we can calculate a
test statistic Ti ¼ ðb1:ib2:iÞ
2
s1:i2þs2:i2 , the ratio between the squared difference of
their reported effects and the sum of their reported sampling
variances. We constructed 30 000 T statistics using markers in linkage
equilibrium along the genome for a pair of cohorts. Under the null
hypothesis of no overlapping samples/heterogeneity, T follows a χ2
distribution with 1 degree of freedom (Supplementary Notes for
Method III).
Analogous to λGC, lmeta ¼ median Tð Þmedianðw21Þ, the ratio between the median
of the 30 000 T values and the median of a χ2 statistic with 1 degree of
freedom (a value of 0.455) has an expected value of 1 for two
independent GWAS summary statistics sets for the same trait. When
there is heterogeneity between estimated genetic effects, the expecta-
tion is λmeta41, and in contrast λmetao1 if there are overlapping
samples. In general, not only overlapping samples but also close
relatives present in different cohorts can lead to correlated summary
statistics generating λmetao1. However, unless the proportion of
overlapping relatives is substantial and their phenotypic correlation
is high, the correlation of the summary statistics due to the effective
number of overlapping samples (no) is expected to be dominated by
the same individuals contributing phenotypic and genetic information
to different cohorts (Supplementary Figure S5). Furthermore, if
genomic control is applied to adjust the sampling variance, then λmeta
will be reduced relative to its value without genomic control for λGC.
GWAS summary statistics for schizophrenia were available in two
phases: the first had 9394 controls and 12 462 cases,14 and in the next
phase ~ 18 000 Swedish samples were added.15 Such a substantial
overlap sample between these two sets of summary statistics led to the
estimated value of λmeta as low as 0.257 (Supplementary Figure S6),
consistent with this known overlap. In contrast, heterogeneity between
data sets (represented by λmeta41) was observed between GWAS
summary statistics of rheumatoid arthritis from European and Asian
studies,16 for which λmeta= 1.09 (Supplementary Figure S7). In
addition, we note that the distribution of the empirical T-statistics
deviates from expectation at the upper tail of the distribution,
suggesting differences in effect size or linkage disequilibrium between
these two ancestries.
Next, we estimated λmeta from pairs of cohorts from the 174 GIANT
height GWAS cohorts.2 We found no evidence for substantial sample
overlap but do observe between-cohort heterogeneity and technical
artifacts. From the 174 GIANT height GWAS,2 we calculated 15 051
cohort pairwise λmeta values, resulting in a bell-shaped distribution
(Figure 2a and b), with the mean of 1.013 and the empirical SD of
0.022, which was greater than theoretical SD of 0.014. The empirical
mean and SD can be used to construct a z-score test for each λmeta.
These results are consistent with a small amount of heterogeneity,
which is not unexpected due to variation of actual (unknown) genetic
architecture and analysis protocols. However, the mean is close to 1.0
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Figure 4 Recovery of cohort-level genetic background for GIANT cohorts using meta-PCA. (a) The recovery of cohort-level genetic background using meta-PCA
analysis for GIANT BMI Metabochip cohorts. The x and y axis represent the first two eigenvectors from meta-PCA. In meta-PCA, Metabochip cohorts could be
classified into African ancestry (AFR), European ancestry (EUR), East Asian Ancestry (EAS), and South Asian Ancestry (SAS). (b) The recovery of cohort-level
genetic background using meta-PCA analysis for GWAS height cohorts. The x and y axis represent the first two eigenvectors inferred from meta-PCA (mPC).
The genetic background inferred with the inclusion of ten 1000 Genomes reference populations. The 1000 Genome cohorts, yellow open circles, were added
for comparison in a–c. The genetic background and relative geographic location for 174 GIANT height cohorts. The large plot on top left was an overview of
174 cohorts, and the rest of plots were classified by the reported demographic information of cohorts. Within each country-level plot, the small black points
represent one cohort, and the large open circle the mean coordinates for those cohorts from the same country.
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and based upon this QC metric, the results are consistent with
stringent QC and data cleaning. The minimum λmeta value was ~ 0.88
(between SORBS men and SORBS women; Figure 2c), with P-
valueo1e− 10 (testing for the difference from 1), and the maximum
was 1.245 (between SardiNIA and WGHS; Figure 2d), with P-
valueo1e− 10, leading to the most deflated and inflated λmeta across
GIANT height study cohorts, both were significant after correction for
multiple testing. Of note, SORBS were analyzed using a method that
corrected for relatedness, which potentially led to the deflated λmeta as
implicated by the theory (Supplementary Notes for Method III).
Illustrating λmeta (Figure 2a) highlighted that 20 cohorts from the
MIGEN consortium showed substantially lower λmeta with many other
cohorts (right-bottom triangle in Figure 2a) than the average,
consistent with over-conservative models for statistical association
analyses being used in these cohorts – which may be due to very small
sample size (ranging from 36 to 320 for the 20 MIGEN cohorts, with
an average sample size of 132). Consistent with this, cohorts from
MIGEN also have many of their λGCo1 (Supplementary Figures S8
and S9). In contrast, the SardiNIA cohort (4303 samples) showed
heterogeneity with nearly all other cohorts (Supplementary Figures S8
and S9), perhaps due to unknown artifacts or a slightly different
genetic architecture for height as result of demographic history.17
The statistical power of detection of overlapping samples is
maximized when a pair of cohorts has equal sample size
(Supplementary Figure S10), or in other words the confidence interval
for null hypothesis of no overlapping samples depends on the sample
sizes for a pair of cohorts. As a comparison, the estimation of a
correlation between the genetic effects for a pair of cohorts has been
proposed to quantify overlapping samples,18,19 but this metric is
confounded with genetic architecture, such as heritability underlying
the trait(s) (Table 1; Supplementary Notes IV). When there was
heritability, the estimated correlation between genetic effects could be
biased and could lead to an incorrect inference about overlapping
samples for a pair of cohorts. When there was no heritability, the
estimated correlation was correct and agreed well with the one
estimated with λmeta. As existence of heritability is one of the reasons
to perform GWAMA, so λmeta is preferred when estimating over-
lapping samples between cohorts.
Another parameterization of λmeta is to estimate it from differences
in allele frequencies between a pair of cohorts instead of differences
between estimated effect sizes (Supplementary Notes III;
Supplementary Figure S11).
Detection of overlapping samples using pseudo profile score
regression
In many circumstances, individual cohorts are not permitted to share
individual-level data, either by national law or by local ethical review
board conditions. Although the metric λmeta can be transformed to
give an estimate of no between cohorts for quantitative traits, it cannot
give an estimate of overlapping samples in case–control studies due to
the ratio of the cases and controls in each study. To get around this
problem, Turchin and Hirshhorn20 created a software tool, Gencrypt,
which utilizes a security protocol known as one-way cryptographic
hashes to allow overlapping participants to be identified without
sharing individual-level data. We propose an alternative approach,
pseudo profile score regression (PPSR), which involves sharing of
weighted linear combinations of SNP genotypes with the central meta-
analysis hub. In essence, multiple random profile scores are generated
for each individual in each cohort, using SNP weights supplied by the
analysis hub, and the resulting scores are provided back to the analysis
hub. PPSR works through three steps (Supplementary Notes for
Method IV; Supplementary Figure S12), and the purpose of PPSR is to
estimate a relationship-like matrix of ni× nj dimension for a pair of
cohorts, which have ni and nj individuals, respectively. Each entry of
the matrix is filled with genetic similarity for a pair of samples from
each of the two cohorts, estimated via the PPSR. The central hub
analysts can determine the best set of SNPs that each individual
analysis hub uses to generate PPS. Without the loss of generality, a set
of loci directly genotyped in all cohorts would make good candidate
set of SNPs for PPS.
We use WTCCC data as an illustration to detect 2934 shared controls
between any two of the diseases by PPSR. Among 330K not palindromic
loci, we randomly picked M= 100, 200, and 500 SNPs, to generate
pseudo profile scores. It generated 21 cohort-pair comparisons, leading
to the summation for 488 587 090 total individual-pair tests. To have an
experiment-wise type I error rate= 0.01, type II error rate= 0.05
(power= 0.95) for detecting overlapping individuals, we needed to
generated at least 57 PPSs. We generated scores S= [s1,s2,s3,…,s57],
where each s is a vector of M elements, sampled from a standard
normal distribution. S is shared across seven cohorts for generating
PPSs for each individual. In total, 57 PPSs were generated for each
Table 1 The estimated correlation for a pair of cohorts via their summary statistics given 30 000 independent loci
h2

n1,2 n1 n2 g1;2 ¼ n1;2ffiffiffiffiffiffiffin1n2p r^1;27SD g^1;27SD
0.25 100 1000 1000 0.1 0.1072±0.0064 0.101±0.0093
1000 2000 0.0707 0.0814±0.0054 0.0709±0.0088
1000 5000 0.0447 0.0615±0.0055 0.0425±0.0096
1000 10 000 0.0316 0.0556±0.0063 0.0325±0.0099
0.25 1 1000 1000 0.001 0.0092±0.0056 0.0017±0.0093
1000 2000 0.0007 0.0126±0.0053 0.0006±0.0079
1000 5000 0.000447 0.0189±0.0060 0.0016±0.0090
1000 10 000 0.000316 0.0259±0.0059 0.0008±0.0092
0 100 1000 1000 0.1 0.0996±0.0052 0.094±0.0085
1000 2000 0.0707 0.0704±0.0048 0.0712±0.0097
1000 5000 0.0447 0.0453±0.0057 0.0441±0.0090
1000 10 000 0.0316 0.0335±0.0057 0.0325±0.0079
Notes: Heritability was simulated on 1000 QTLs. We also tried 100 QTLs, and results were nearly identical; n1, n2, and n1,2 represent the sample size for cohort 1, 2, and overlapping samples
between them. γ1,2 represents the true correlation for a pair of summary statistics due to overlapping samples. r^1;2 represents the estimated correlation estimated via direct correlation between summary
statistics, the method proposed by Bolormaa et al.18 and Zhu et al.19. g^1;2 represents the estimated correlation estimate via λmeta, g^1;2 ¼ 1l^meta2 ffiffiffiffiffiffiffin1 n2p
n1þn2
.
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individual in each cohort. For a pair of cohorts, PPSR was
conducted for each possible pair of individuals for any two cohorts
over the generated PPSs. Once the regression coefficient (b) was
greater than the threshold, here b= 0.95, the pair of individuals was
inferred to be having highly similar genotypes, implying that the
individual was included in both cohorts (Supplementary Notes for
Method IV).
When using 200 and 500 random SNPs, all the known 2934 shared
controls were detected from 21 cohort-pairwise comparison; when
using 100 randomly SNPs, on average 2931 shared samples were
identified, which is more accurate than using λmeta constructed using
either genetic effects or allele frequencies (Figure 3a). In addition, for
detected overlapping samples, there were no false positives observed –
consistent with simulations that show the method was conservative in
the controlling type I error rate (Supplementary Notes for Method
IV). For comparison, we also used the Gencrypt to detect overlapping
samples using the same set of SNPs as used in PPSR. Although
Gencrypt guidelines suggest use of at least 20 000 random SNPs,20
selecting 500 random SNPs in the WTCCC cohorts also provided
good accuracy with Gencrypt, and on average about 2920 (99.6% of
the shared controls) overlapping samples were detected, only slightly
lower than PPSR. For example, for BP and CAD, Gencrypt detected
2912 shared controls, but was unable to identify ~ 20 overlapping
controls, due to missing data (on average 1% missing rate).
Furthermore, PPSR is able to detect pairs of relatives. For example,
between the BD and CAD cohorts, two pairs of apparent first-degree
relatives were detected (Figure 3b). To find additional first-degree
relatives between BD and CAD cohorts, at least 265 PPSs were
required to have a type I error rate of 0.01 and type II error rate of
0.05 for a regression coefficient cutoff of 0.45, a threshold for first-
degree relatives. As expected, all other individuals that did not show
high relatedness did not reach the threshold of 0.45 of the PPS
regression coefficient for first-degree relatives (Figure 3c). Gencrypt
did not detect any first-degree relatives.
PPSR for each individual uses very little personal information and
can be minimized so that there is very low probability of decoding it.
One way to attempt to decode the genotypes from PPS is to reverse
the PPSR, so that the individual genotypes can be predicted in the
regression (Supplementary Notes for Method IV). The individual-level
genotypic information that can be recovered by an analyst, who knows
the S matrix (the weights for generating PPS), is determined by the
ratio between the number of markers (M) that generated PPS and the
number of PPS (K). Therefore, inferred information on individual
genotypes can be minimized and tailored to any specific ethics
requirements. We suggest MK45B10 to protect the privacy with
sufficient accuracy (Figure 3d).
DISCUSSION
In this study, we provide four metrics for monitoring and improving
the quality of large-scale GWAMA based on summary statistics. Using
the Fst-derived genetic distance measure, we can place all cohorts on
an inferred geographic map and can easily identify cohorts that are
genetic outliers or that have unexpected ancestry. In application, we
should note that the Fst measure can identify unusual summary
information, such as detected in the MIGEN cohorts from GIANT
Consortium GWAMAs, in which the same allele frequencies were
reported for all cohorts. Meta-PCA can also be used to infer the
genetic background of cohorts. The high concordance between Fpc and
meta-PCA indicates the both methods are robust.
In practice, meta-PCA is much easier to implement when there are
many cohorts, but FPC that has close-form analytical results provides a
theoretical ground for meta-PCA. There are limitations for both FPC
and meta-PCA. First, FPC depends on the choice of reference cohorts,
such as 1KG reference cohorts, and the projection may be slightly
different when other reference cohorts are adopted. Resembling any
PCA, the projection from meta-PCA depends on the context of all
cohorts, and the inclusion or exclusion of other cohorts will change
the projection slightly. However, we believe the impact will not
influence the inference of the genetic background of cohorts in a
meta-analysis. Second, various mechanisms can give an identical
projection in PCA. The purpose of both methods is to find the
discordance between demographic information and genetic informa-
tion, or outliers, in GWAMA.
Our third metric λmeta provides information on sample overlap and
heterogeneity between cohorts by utilizing the estimated allelic effect
sizes and their standard errors. In most meta-analyses, the overall λmeta
is likely to be slightly 41 solely due to unknown heterogeneity, slight
as observed, in generating the phenotype and genotype data that
cannot be accounted for by QC. The observed mean of λmeta for the
GIANT height GWAMA was 1.03 but with more variation than
expected by chance. The strong correlation between λGC and λmeta
indicated the reported sampling of the reported data were system-
atically driven by analysis protocols, such as single-marker regression
and linear mixed model methods. For cohorts with λGCo1 and
λmetao1, it is likely that the GWAS modeling strategy employed for
GWAS in the cohort was too conservative, eg, MIGEN cohorts might
have on average too small sample size for each cohort. Conversely, for
cohorts with λGC41 and λmeta41, results are too heterogeneous,
perhaps reflecting systematically smaller sampling variances of the
reported genetic effects. As GWAMA often uses inverse-variance-
weighted meta-analysis,21 such cohorts may lead to incorrect weights
to the different cohorts in the meta-analysis, suggesting that the
statistical analysis in meta-analyses can be improved by applying better
weighting factors.
It is well recognised that overlapping samples may inflate the type-I
error rate of GWAMA and therefore lead to false positives. Although
post hoc correction of the test statistic is possible,18,19,21 stringent QC
ruling out overlapping samples makes the whole analysis easier and
lowers the risk of false positives. A better solution would be to rule out
shared samples at the start, for pairs of cohorts that show deflated
λmeta, and we propose PPSR to accomplish this.
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